Document Type
Journal Article
Publication Date
8-1-2013
Journal
PLoS ONE
Volume
Volume 8, Issue 8
Inclusive Pages
Article number e71495
Keywords
cdc42 GTP-Binding Protein--metabolism; p21-Activated Kinases--metabolism; rac GTP-Binding Proteins--metabolism
Abstract
P21-activated kinase 1 (PAK1) is activated by binding to GTP-bound Rho GTPases Cdc42 and Rac via its CRIB domain. Here, we provide evidence that S79 in the CRIB domain of PAK1 is not directly involved in this binding but is crucial for PAK1 activation. S79A mutation reduces the binding affinity of PAK1 for the GTPases and inhibits autophosphorylation and kinase activity of PAK1. Thus, this mutation abrogates the ability of PAK1 to induce changes in cell morphology and motility and to promote malignant transformation of prostate epithelial cells. We also show that growth of the prostate cancer cell line PC3 is inhibited by the treatment of a PAK1-inhibiting peptide comprising 19 amino acids centered on S79, but not by the PAK1 peptide containing the S79A mutation, and that this growth inhibition is correlated with reduced autophosphorylation activity of PAK1. Together, these findings demonstrate a significant role of S79 in PAK1 activation and provide evidence for a novel mechanism of the CRIB-mediated interaction of PAK1 with Cdc42 and Rac.
Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.
APA Citation
Shin, Y.J., Kim, E.H., Roy, A., Kim, J.H. (2013). Evidence for a novel mechanism of the PAK1 interaction with the Rho-GTPases Cdc42 and Rac. PLoS ONE, 8(8):e71495.
Peer Reviewed
1
Open Access
1
Comments
Reproduced with permission of PLoS ONE